The Greater Cannabis Company Files Additional Patent to Further Protect Proprietary Cannabinoid Delivery System

Baltimore, MD, Oct. 11, 2018 (GLOBE NEWSWIRE) — The Greater Cannabis Company, Inc. (OTC: GCAN) (“the Company”), a biotechnology company focused on development and manufacturing of innovative delivery systems for the Cannabis market, today announced that it has filed an additional patent to further protect its proprietary Eluting Transmucosal Patch (ETP) platform. The United States Patent and Trademark Office has accepted the filing entitled, Oral Dissolving Film for Rapid and Sustained Release and Delivery of Cannabinoids, and as of September 27, 2018 has issued the Company a priority application number of US 62/737,153. The Company’s ETP technology has a unique more at